Month: December 2013

Shimadzu Corporation announces application of mass microscope technology for molecular imaging of anticancer drug action

In a collaborative study with the National Cancer Center, nano-surface and molecular-orientation limited (nSMOL) proteolysis of antitumor antibodies was used to determine their effective concentration in tumor tissue. The method will be further developed to visualize the pharmacokinetics of other drugs Shimadzu Corporation news release, December 18, 2013

Team at Kumamoto University succeeds to develop complex kidney structures from human iPS cells

By using an appropriate combination of progenitor cells, which were developed from iPS cells, the group was able to develop 3D structures of a functional kidney in vitro, including glomeruli with podocytes and renal tubules with proximal and distal regions and clear lumina. Atsuhiro TAGUCHI et al., CellStemCell

iPS Cell Research Institute, Kyoto: immortalized erythroblasts enable large-scale production of human erythrocytes

A consortium led by Kyoto’s iPS Cell Research Institute has shown that erythroblasts derived from human pluripotent stem cells and immortalized by overexpression of c-MYC and BCL-XL allowed for the production of human erythrocytes in large scale. Sho-ichi HIROSE et al., Stem Cell Reports doi: 10.1016/j.stemcr.2013.10.010

Scroll to top